The Pathobiochemistry of Hereditary Pancreatitis: Studies on Recombinant Human Cationic Trypsinogen

Pancreatology

Volumn 1, Issue 5, 2001, Pages 461-465

  Sahin Tóth, Miklós ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ecotin affinity chromatography; Hereditary pancreatitis; Human cationic trypsinogen; Trypsin autolysis; Trypsinogen autoactivation

Indexed keywords

PRSS2 PROTEIN, HUMAN; RECOMBINANT PROTEIN; TRYPSIN; TRYPSINOGEN;

AUTOLYSIS; CATALYSIS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HUMAN; KINETICS; METABOLISM; PANCREATITIS; PATHOLOGY; PHYSIOLOGY; REVIEW;

AUTOLYSIS; CATALYSIS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; KINETICS; PANCREATITIS; RECOMBINANT PROTEINS; TRYPSIN; TRYPSINOGEN;

EID: 0035552556     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000055848     Document Type: Article

References (13)

1. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, Martin SP, Gates LK Jr, Amann ST, Toskes PP, Liddle R, McGrath K, Uomo G, Post JC, Ehrlich GD: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996;14:141-145.
2. Gorry MC, Gabbaizedeh D, Furey W, Gates LK Jr, Preston RA, Aston CE, Zhang Y, Ulrich C, Ehrlich GD, Whitcomb DC: Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology 1997;113:1063-1068.
3. Teich N, Mossner J, Keim V: Mutations of the cationic trypsinogen in hereditary pancreatitis. Hum Mutat 1998;12:39-43.
4. Nishimori I, Kamakura M, Fujikawa-Adachi K, Morita M, Onishi S, Yokoyama K, Makino I, Ishida H, Yamamoto M, Watanabe S, Ogawa M: Mutations in exons 2 and 3 of the cationic trypsinogen gene in Japanese families with hereditary pancreatitis. Gut 1999;44:259-263.
5. Ferec C, Raguenes O, Salomon R, Roche C, Bernard JP, Guillot M, Quere I, Faure C, Mercier B, Audrezet MP, Guillausseau PJ, Dupont C, Munnich A, Bignon JD, Le Bodic L: Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis. J Med Genet 1999;36:228-232.
6. Várallyai É, Pál G, Patthy A, Szilágyi L, Gráf L: Two mutations in rat trypsin confer resistance against autolysis. Biochem Biophys Res Commun 1998;243:56-60.
7. Sahin-Tóth M: Hereditary pancreatitis-associated mutation Asn21 → Ile stabilizes rat trypsinogen in vitro. J Biol Chem 1999;274:29699-29704.
8. Sahin-Tóth M, Gráf L, Tóth M: Trypsinogen stabilization by mutation Argl 17 → His: A unifying pathomechanism for hereditary pancreatitis? Biochem Biophys Res Commun 1999; 264:505-508.
9. 2+ binding inhibits autoactivation of rat trypsinogen. Biochem Biophys Res Commun 2000;275: 668-671.
10. Sahin-Tóth M: Human cationic trypsinogen: Role of Asn21 in zymogen activation and implications in hereditary pancreatitis. J Biol Chem 2000;275:22750-22755.
11. Sahin-Tóth M, Tóth M: Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen. Biochem Biophys Res Commun 2000;278:286-289.
12. Lengyel Z, Pál G, Sahin-Tóth M: Affinity purification of recombinant trypsinogen using immobilized ecotin. Protein Expr Purif 1998;12: 291-294.
13. Szilágyi L, Kénesi E, Katona G, Kaslik G, Juhász G, Gráf L: Comparative in vitro studies on native and recombinant human cationic trypsins: Cathepsin B is a possible pathological activator of trypsinogen in pancreatitis. J Biol Chem 2001;276:24574-24580.